|
HS Code |
727475 |
| Chemical Name | 3-Pyridinecarboxamide, 2-chloro-6-(trifluoromethyl)- |
| Molecular Formula | C7H4ClF3N2O |
| Molecular Weight | 224.57 g/mol |
| Cas Number | 959162-98-4 |
| Appearance | Solid (typically off-white to light yellow powder) |
| Boiling Point | Decomposes before boiling |
| Solubility | Slightly soluble in water; soluble in organic solvents (e.g., DMSO, methanol) |
| Smiles | C1=CC(=NC(=C1C(=O)N)Cl)C(F)(F)F |
| Inchi | InChI=1S/C7H4ClF3N2O/c8-6-4(7(9,10)11)2-1-5(3-13)12-6/h1-2H,(H2,12,13) |
| Purity | Typically ≥98% (supplier dependent) |
| Storage Conditions | Store at room temperature, dry and protected from light |
| Synonyms | 2-Chloro-6-(trifluoromethyl)nicotinamide |
| Hazard Class | Consult safety data sheet (potential irritant) |
As an accredited 3-Pyridinecarboxamide, 2-chloro-6-(trifluoromethyl)- factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Amber glass bottle, 25g, screwed cap, labeled with chemical name, CAS number, hazard pictograms, and manufacturer details for laboratory use. |
| Container Loading (20′ FCL) | 20′ FCL container loaded with 3-Pyridinecarboxamide, 2-chloro-6-(trifluoromethyl)-: securely packed drums/pallets, moisture-protected, compliant with chemical transport regulations. |
| Shipping | Shipping for **3-Pyridinecarboxamide, 2-chloro-6-(trifluoromethyl)-** requires secure, chemical-resistant packaging to prevent leaks or contamination. The chemical should be transported as per relevant regulations (such as IATA or DOT), with clear labeling and a Safety Data Sheet (SDS) included. Handle with care and store in a cool, dry environment. |
| Storage | Store 3-Pyridinecarboxamide, 2-chloro-6-(trifluoromethyl)- in a tightly sealed container in a cool, dry, well-ventilated area away from incompatible substances such as strong oxidizers. Protect from moisture and direct sunlight. Use secondary containment if necessary to prevent spills. Label container clearly and store at room temperature or as specified in the safety data sheet. Avoid inhalation and contact with skin or eyes. |
| Shelf Life | 3-Pyridinecarboxamide, 2-chloro-6-(trifluoromethyl)- typically has a shelf life of 2–3 years when stored in a cool, dry, sealed container. |
|
Purity 98%: 3-Pyridinecarboxamide, 2-chloro-6-(trifluoromethyl)- with a purity of 98% is used in pharmaceutical intermediate synthesis, where it ensures high yield and reduced impurity levels. Melting Point 120°C: 3-Pyridinecarboxamide, 2-chloro-6-(trifluoromethyl)- with a melting point of 120°C is used in solid-formulation research, where it provides stable crystal morphology and consistent handling. Particle Size ≤50 µm: 3-Pyridinecarboxamide, 2-chloro-6-(trifluoromethyl)- at particle size ≤50 µm is used in high-performance liquid chromatography (HPLC) sample preparation, where it allows improved solubility and homogeneous dispersal. Stability Temperature 60°C: 3-Pyridinecarboxamide, 2-chloro-6-(trifluoromethyl)- stable at 60°C is used in process development studies, where it maintains chemical integrity during thermal cycling. Moisture Content ≤0.2%: 3-Pyridinecarboxamide, 2-chloro-6-(trifluoromethyl)- with moisture content ≤0.2% is used in active pharmaceutical ingredient (API) formulation, where it prevents hydrolysis and ensures long-term shelf stability. Molecular Weight 252.59 g/mol: 3-Pyridinecarboxamide, 2-chloro-6-(trifluoromethyl)- with molecular weight 252.59 g/mol is used in medicinal chemistry programs, where it enables accurate stoichiometric calculations and reproducible bioactivity screening. |
Competitive 3-Pyridinecarboxamide, 2-chloro-6-(trifluoromethyl)- prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615371019725 or mail to sales7@boxa-chem.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: sales7@boxa-chem.com
Flexible payment, competitive price, premium service - Inquire now!
Few compounds hold a place on a chemist’s shelf for both performance and reliability quite like 3-Pyridinecarboxamide, 2-chloro-6-(trifluoromethyl)-. We have produced volumes of this compound in our facilities for years, watching how its unique properties shape innovation in fields from pharmaceuticals to fine chemical synthesis. Our team, from line operators to technical chemists, sees every kilogram leave the reactor with a clear sense of why high standards always matter—because this material often ends up as a critical building block, sometimes even in life-saving medicines.
Many reactions demand intermediates that not only survive harsh environments but also introduce features that open doors to new chemistry. 3-Pyridinecarboxamide, 2-chloro-6-(trifluoromethyl)- stands out because the pairing of a chlorine at position 2 and a trifluoromethyl group at position 6 on the pyridine ring delivers much more than just atomic modifications. This combination reliably gives synthetic chemists a versatile handle for cross-coupling reactions, nucleophilic substitutions, and functional group interconversions.
For researchers, synthetic predictability can make the difference between a productive campaign and months wasted troubleshooting. Our own R&D teams have run dozens of test reactions with this compound, pushing its limits to find out where it shines and where challenges arise. In Suzuki and Buchwald-Hartwig couplings, we’ve observed that the trifluoromethyl group’s electron-withdrawing power sometimes even enhances catalyst turnover, translating to higher yields and cleaner reactions.
Over the years, chemists have looked for ways to tweak the electronic character of a pyridine ring and tune its reactivity. Other related products, such as simple 3-pyridinecarboxamides or derivatives lacking halogen or fluorinated substituents, often miss the mark in demanding synthetic sequences. Their lack of either steric protection or electron-withdrawing capability can lead to poor selectivity, troublesome side reactions, and increased purification headaches.
With 2-chloro-6-(trifluoromethyl)- substitution, the compound manages to walk a fine line, balancing stability with reactivity. The chlorine atom on the ring blocks certain positions from attack, focusing reactivity on intended sites. At the same time, the trifluoromethyl group slims the electron density, increasing resistance to hydrolysis and oxidation during prolonged reaction sequences. We’ve seen this benefit directly in process scale-ups—specifically in extended synthetic routes where oxidation stability outweighs almost anything else for process engineers.
Comparisons with other halogenated pyridinecarboxamides reveal something else: although bromine and iodine analogues can sometimes offer increased reactivity for certain couplings, they tend to present setbacks in cost, raw material availability, and sometimes even in the reliability of downstream processes. Chlorine, in our hands, brings reproducibility batch after batch, which our customers recognize and value.
From a manufacturing standpoint, not every batch tells the same story. Over time we’ve learned how to manage the multiple stages that bring this molecule to life, from aromatic nucleophilic substitution through amide formation to meticulous purification. Our approach has evolved, emphasizing tight temperature control and carefully timed quenching—details that only those of us actually performing the work would emphasize.
Purity demands more than just following a recipe. We run high-resolution HPLC with trace-level impurity analysis, always comparing each fresh batch to multiple reference standards. Certain by-products—unreacted halopyridines, hydrolyzable trifluoromethylbenzenes—cannot hide from our QC team. Years of feedback from downstream users, especially those scaling from gram to multi-kilogram applications, have shaped our own improvements in crystallization and solvent systems; we often switch up from DMF-based workups to ethyl acetate-hydrocarbon systems for cleaner yields, less residual solvent, and better product handling.
We’ve been called in more than once as trouble-shooters for customers facing failed batches and unexplained color shifts when sourcing from third parties. It usually traces back to subtle differences in purification or solvent residues. There’s a direct link between our investments in analytical validation and the reduced number of failed runs at customer sites. Our ethos rests on that chain of trust—realized through strong science, not marketing.
Demand for this particular pyridinecarboxamide doesn’t come from just one sector. In pharmaceuticals, the molecule often finds a place in heterocyclic scaffold construction or intermediate building in anti-infective and oncologic lead compounds. Compounds featuring the 2-chloro-6-(trifluoromethyl) motif tend to show altered pharmacokinetics and metabolic stability, attributes increasingly specified by medicinal chemists for new drug candidates.
We’ve worked closely with academic labs hunting for enzyme inhibitors and with biotech companies striving for new probe molecules. The feedback is similar: starting from a well-defined, reproducible material narrows experimental noise and accelerates lead optimization. By being there to answer questions on solubility, batch consistency, and compatibility, we’ve learned where improvement is both possible and necessary.
Handling of 3-Pyridinecarboxamide, 2-chloro-6-(trifluoromethyl)- takes on special significance during scale-up. The relatively high melting point and moderate solubility in polar aprotic solvents present challenges for those unfamiliar with these patterns. Our own process teams have optimized dispersion in various solvent mixtures and taken care to avoid clumping or agglomeration during storage, which can create weighing inconsistencies and dosing errors in automated systems.
The compound resists decomposition under standard storage but, like many fine chemicals, benefits from being kept away from excess moisture and reactive bases. We have set up desiccant protocols and monitored storage rooms before a single batch ever ships out. These precautions often sound simple; in practice they are the small differences separating a reliable supplier from sources producing three lots with three different properties.
Through years of feedback, we’ve modified packaging and labeling conventions, dropping old-style glass bottles in favor of high-barrier pails outfitted with liners. Clean dispensing and transfer methods, free from static, leave much less room for trace contamination or batch drift.
Requests for tight assay and impurity profiles are standard in our business. On more than one occasion, customers have returned with requests for narrower impurity windows following regulatory feedback or new synthetic needs. We always aim for our main product to test above 98% purity by HPLC, with well-documented impurity profiles covering even minor unknowns down to low-hundred-ppm levels. The data doesn’t just sit in a file; it gets discussed at project kickoff and reviewed with our partners as their project progresses.
Solvent residue presents another consideration. We use modern vacuum stripping and solvent exchange methods in late-stage processing, ensuring residuals always fall well below ICH Q3C guidelines for both common and less-tracked solvents. Many of our partners now require formal certificates listing each potential residual, not just the most common. Thorough documentation means fewer questions late in a project lifecycle, especially as pilot and commercial batch sizes grow.
In the landscape of pyridinecarboxamide derivatives, small structural changes often have outsized consequences. By comparison, a 2-chloro-3-pyridinecarboxamide lacking the trifluoromethyl group frequently reacts too quickly in basic environments, leading to side product formation and double addition in cross-couplings. Similarly, variants with only a trifluoromethyl group but no halogen see much less selective activation, burdening researchers with lengthy purification and lower overall yields.
Adding both substituents in this arrangement stabilizes the molecular core without sacrificing versatility—a point not just observed on paper but confirmed in our customer labs with repeated synthetic sequences. Pharmaceutical researchers with direct synthesis experience have noted the absence of problematic rearrangements or exothermic decomposition, hazards sometimes seen in using more electron-rich or poorly protected analogues. These are not theoretical strengths: they emerge from routine, scaled use in real world laboratories and production suites.
Further, some competitors in the market still offer mixtures or poorly characterized material—often with a noticeable yellow or brown coloration, a sign of unfiltered tar-like byproduct or incomplete phase separation. Our long-standing practice removes these colored impurities through charcoal filtration and highly selective crystallization, ultimately leading to a colorless or faintly off-white product with high reproducibility in downstream chemistry.
Comparison between lab-scale and multi-ton production separates those who actually run the reactors and the vendors only reshuffling supplied inventory. An experienced chemist knows that even a fraction of a percent impurity, or a slight shift in water content, can topple an otherwise robust process. Direct manufacturing gives us the ability to tweak and perfect every stage, from initial chlorination to final drying under vacuum. Requests for large, consistent lots or tailored packing can only be answered by those who hold the process knowledge.
Anecdotally, we’ve seen runs from other sources derail multi-week syntheses through subtle amounts of less-volatile byproducts or unreliable melting behavior. Chemists working directly with us at process transfer stages frequently comment on their perceived reliability of our samples, compared to tertiary market offerings. These testimonials matter more than any third-party review—they reflect the actual lived experience of researchers, project managers, and production staff.
Collaboration sits at the core of our practice. Not infrequently, we are called into technical meetings to discuss not just product supply but also troubleshooting solubility or reaction bottlenecks. Sharing what has worked for us—such as adjusting solvent ratios for optimal dissolution, recommending pre-drying prior to use, or highlighting stability in high-throughput robotic platforms—has saved time and money for partners across research, pilot, and commercial scales.
We supply documentation beyond standard specs, including analytic support for downstream stability studies and method validation in new synthetic applications. Part of our job consists of anticipating regulatory expectations for traceability, process control, and batch-to-batch record retention. In an environment of rising regulatory attention in pharmaceutical supply, these steps make a difference. Years of navigating this path with partners means we build shared confidence, not just a paper trail.
Feedback from both small start-ups and established multinationals continues to shape our internal practices—driving tighter analytical controls, faster response times to technical queries, and ambitious continuous improvement targets.
The story doesn’t end once a batch leaves our facility. With rising expectations for sustainable production, our team invests time and attention in improving the environmental impact across the lifecycle of each product we ship. We’ve introduced solvent recycle trains and optimized energy use in batch reactions to reduce the carbon footprint of 3-Pyridinecarboxamide, 2-chloro-6-(trifluoromethyl)-. Careful waste segregation and responsible sourcing for raw materials now form part of every project planning session. None of these initiatives reflect marketing strategy; they reflect direct pressure from our own chemists who see waste and inefficiency before anyone else.
With improved process planning, we now reclaim upwards of 30% of our process solvents—an achievement not possible without years of incremental improvement and investment in reaction monitoring. We routinely work with partners to assess the potential impact of shifting reagent sources or adopting greener alternatives, always weighing upstream change against downstream purity and process safety.
Staying ahead of new requirements, whether they come from regulatory agencies, customers, or advances in green chemistry, presents us with ongoing challenges. We routinely evaluate our supply chain to safeguard both the security of raw materials and the ethical sourcing of specialty reagents. Raw material volatility—especially those involving fluorinated intermediates and specialized chlorinating reagents—requires a broad network of trusted partners. Supply chain disruptions in the past have taught us to maintain larger stocks of critical reagents and invest in rapid switch-overs between supplier routes.
A developing area of concern is the tightening scrutiny around fluorinated materials—both their persistence in the environment and the requirement for transparent lifecycle management. Managing these requirements, especially in jurisdictions facing stricter reporting and disposal rules, forms an active agenda item in technical and regulatory meetings. For us, sustainability and accountability are not obstacles. They are opportunities to drive improvement and reinforce our promise to our partners, both in the lab and out in the field.
Anyone can recite catalog entries or republish standard specs. What sets a dedicated manufacturer apart is the deep experience drawn from every batch, the willingness to test, and to listen when reactions fail or succeed unexpectedly. Over time, our facility has seen bright new graduates and seasoned process veterans all bring their learning and their pride to each run—fixing small problems before they become big ones, and treating each shipment as a bond between our team and yours.
Our story with 3-Pyridinecarboxamide, 2-chloro-6-(trifluoromethyl)- continues to evolve, fueled by new applications and higher standards. The chemical’s distinct features, its performance under pressure, and the shared history with those who put it to work in their own labs create a narrative built on trust, science, and direct accountability. This is chemistry with purpose, shaped by real-world demands and continual improvement, year after year.